Healio’s top ophthalmic business-related items in 2023 covered the changing landscape of determining prices for drugs in the U.S. and the recall of generic artificial tears.
Check out the year’s top ophthalmic business items below.
BLOG: The ‘would you rather’ rule for drug pricing
Historically in the United States, Medicare has not had the legal authority to negotiate the prices of drugs. Essentially, drug prices were unregulated. Read more.
BLOG: Sometimes brand matters: FDA forces recall of 27 generic artificial tears
Oh my. Another FDA recall of generic artificial tears